Growth Metrics

Oculis Holding AG (OCS) Leases (2022 - 2026)

Quarterly Leases rose 122.93% to $3.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.0 million through Mar 2026, up 122.93% year-over-year, with the annual reading at $3.1 million for FY2025, 107.18% up from the prior year.

Oculis Holding AG's Leases history spans 5 years, with the latest figure at $3.0 million for Q1 2026.

  • Leases came in at $3.0 million for Q1 2026, down from $3.1 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $3.2 million in Q3 2025 to a low of $786820.6 in Q4 2022.
  • The 5-year median for Leases is $1.4 million (2025), against an average of $1.6 million.
  • Year-over-year, Leases decreased 13.88% in 2025 and then surged 122.93% in 2026.
  • Oculis Holding AG's Leases stood at $786820.6 in 2022, then rose by 8.18% to $851152.6 in 2023, then soared by 74.75% to $1.5 million in 2024, then skyrocketed by 107.18% to $3.1 million in 2025, then decreased by 2.0% to $3.0 million in 2026.
  • Per Business Quant, the three most recent readings for OCS's Leases are $3.0 million (Q1 2026), $3.1 million (Q4 2025), and $3.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Leases (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 83,048.00
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - 61,822.50
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 285.20 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 1.69 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn -
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 189.30 Mn
10 Oculis Holding AG 24.51 Bn 24.21 Bn - 3.02 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3.02 Mn
Dec 31, 2025 3.08 Mn
Sep 30, 2025 3.22 Mn
Jun 30, 2025 1.40 Mn
Mar 31, 2025 1.35 Mn
Dec 31, 2024 1.49 Mn
Sep 30, 2024 1.60 Mn
Jun 30, 2024 1.62 Mn
Mar 31, 2024 823,745.58
Dec 31, 2023 851,152.63
Sep 30, 2023 903,457.75
Jun 30, 2023 928,666.58
Dec 31, 2022 786,820.61